"10.1371_journal.pone.0078885","plos one","2013-11-13T00:00:00Z","Mehdi Mesri; Charlie Birse; Jenny Heidbrink; Kathy McKinnon; Erin Brand; Candy Lee Bermingham; Brian Feild; William FitzHugh; Tao He; Steve Ruben; Paul A Moore","Celera, Alameda, California, United States of America","Conceived and designed the experiments: MM CB SR WF TH PM. Performed the experiments: MM JH KM EB CLB BF TH. Analyzed the data: MM JH KM EB CLB WF PM. Contributed reagents/materials/analysis tools: CB WF. Wrote the paper: MM JH PM.","The authors have the following interests. This study was funded by and performed at Celera, the employer of all authors during the course of these studies. Celera has 3 issued US patents to declare: 7,582,441, 8,110,373, and 8,334,106, describing associations of Na-K ATPase beta3 protein in various malignant states. There are no products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","11","Mehdi Mesri","MM",11,TRUE,6,7,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
